Financial News
Merck’s COVID-19 pill could pose risks during pregnancy: report
December 15, 2021 at 12:54 PM EST
While the Food and Drug Administration (FDA) is expected to soon rule on whether to authorize Merck's COVID-19 pill, questions remain regarding its risks in pregnant women.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
